Nitin Ohri, MD | Montefiore Einstein

Dr. Nitin Ohri

Claim this profile

Montefiore Medical Center-Einstein Campus

Studies Lung Cancer
Studies Small Cell Lung Cancer
17 reported clinical trials
44 drugs studied

About Nitin Ohri

Education:

  • Earned an MD (Doctor of Medicine) degree.
  • Holds an MS (Master of Science) degree.

Experience:

  • Currently serves as a Professor in the Department of Radiation Oncology at Montefiore Medical Center-Einstein Campus.
  • Specializes in radiation oncology with a focus on lung cancer and gastrointestinal cancer.

Area of expertise

1Lung Cancer
Nitin Ohri has run 10 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage IV
Stage I
2Small Cell Lung Cancer
Nitin Ohri has run 5 trials for Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
Montefiore Medical Center-Einstein Campus
Image of trial facility.
Montefiore Medical Center - Moses Campus

Clinical Trials Nitin Ohri is currently running

More about Nitin Ohri

Clinical Trial Related10 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Nitin Ohri has experience with
  • Atezolizumab
  • Cisplatin
  • Radiation Therapy
  • Carboplatin
  • Etoposide
  • Stereotactic Body Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Nitin Ohri specialize in?
Is Nitin Ohri currently recruiting for clinical trials?
Are there any treatments that Nitin Ohri has studied deeply?
What is the best way to schedule an appointment with Nitin Ohri?
What is the office address of Nitin Ohri?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security